The Contrast Media Market is expected to experience a steady growth rate of 5-6% CAGR. Key drivers of this growth include innovations in imaging technologies, the rising incidence of chronic ...

Problem: Recently, the Centers for Disease Control and Prevention (CDC) reiterated its position calling for medications labeled as "single dose" or "single use" to be ...

Hysterosalpingography (HSG) remains a cornerstone diagnostic and potentially therapeutic procedure in the evaluation of female infertility. The technique involves the injection of contrast media into ...

Recent research, led by Dushyant Sahani MD, Professor and Chair of Radiology at the University of Washington and presented at the 2022 Radiological Society of North America (RSNA) Congress, ...

New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the end of 2027 i Demand for CT and X-Ray contrast media, ...

The American College of Radiology (ACR) and the American Academy of Allergy, Asthma & Immunology (AAAAI) issued a consensus statement in 2025 that harmonizes previously divergent viewpoints on ...

Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...

Eyeing an expected leap in demand for contrast media—used in X-rays, CT scans and more—GE HealthCare is upping its stake in the Emerald Isle. The company is pumping $138 million into its Carrigtwohill ...

A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can ...